SUBSCRIBE
SUBSCRIBE
News   Business

Horizon Discovery Ltd. Sign Cancer Metabolomics Service Agreement with Global Pharma GlaxoSmithKline

October 13, 2009 | 
1 min read
Horizon Discovery -- Horizon Discovery (Horizon) today announced it has signed a commercial service agreement with Global Pharmaceutical company; GlaxoSmithKline relating to its X-MAN technology.
Alliances Europe
GSK
MORE ON THIS TOPIC
Insights
France’s biotech ecosystem: science, capital and scale
May 28, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Kardigan cozies up to public markets to support heart disease drugs
May 27, 2026
 · 
14 min read
 · 
Editorial Team
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
J&J trims New Jersey headcount by 56
May 27, 2026
 · 
56 min read
 · 
BioSpace Editorial Staff
Podcast
Lilly wheels and deals, Moderna gets boost on hantavirus scare, ASCO excitement builds
May 27, 2026
 · 
2 min read
 · 
Jef Akst